PhD Candidate for the Project “Moving Animals: A History of Science, Media and Policy in the Twentieth Century””
Ongeveer 5 uur geleden - Universiteit Maastricht - Maastricht
Currently, approximately 40-60% of drugs prescribed to children are off-label. Their efficacy and safety have not been adequately studied. This leaves …
Currently, approximately 40-60% of drugs prescribed to children are off-label. Their efficacy and safety have not been adequately studied. This leaves children at an increased risk of therapy failure or drug toxicity. One of the main roadblocks to adequately studying drugs in children, is lacking infrastructure to perform both industry and investigator-initiated trials. This leads to delayed or even cancelled trials, thereby not contributing to more effective and safe therapy, and resulting in wasted resources. To address this lack of successful pediatric trials, the Innovative Medicines Initiative provides funding to build a European-wide pediatric trial network.
As part of these activities a Dutch Pediatric Trial Network (PEDMED) will be built. The EU network will be tested by performing 6-8 multi-national multi-center pediatric drug trials, in which the Dutch network aims to participate. This project aims to develop a sustainable Dutch Pediatric Clinical Trial Network, aimed to facilitating industry and investigator-driven pediatric clinical trials in university and general hospitals across The Netherlands. In this project, Radboudumc will coordinate these Dutch activities, in collaboration with EU academic and industry partners
We expect the project manager to build upon existing pediatric trial and research network infrastructure, working with relevant stakeholders including pediatricians and their existing networks, trial offices/ coordinators, the Dutch Clinical Research Foundation, hospital administration, research funders, government and the EU network. The initial network metrics will be success of IMI trial acquisition and trial recruitment in The Netherlands. Long-term metrics will be sustainability to support both industry and investigator-trials. This position presents an unique opportunity to be part of the largest European pediatric research infrastructure project (130 million euros, 6 years) to date and ultimately contribute to effective and safe drug therapy for children.
You should be a pro-active and enthusiastic research project manager, research coordinator or similar, with an MSc (or BSc with proven experience at Master level) in Medicine, Biomedical Sciences, Pharmacy or Nursing, with a clear interest in clinical trial management and network building. Good communication skills (Dutch and English), expertise/experience in (international) multi-center clinical trials are essential. You are able to make a plan and organize activities to achieve goals.
Experience with pediatric trials and network building is a pre. Willingness and flexibility to regularly travel nationally and incidentally in Europe is a prerequisite. The project manager is expected to work in collaboration with the two other project managers and secretariat for all ongoing European pediatric research infrastructure activities at the Department of Pharmacology and Toxicology.
You recognize yourself in the Radboud way of working.